Evidence method
Level · gp.fundamentals.capex_revenue_ratio
242.52% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ABCL · Mar 31, 2024
AbCellera Biologics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-24-021159General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-419.01% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-18.36% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-551.48% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
394.69% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
174.89% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History18 statesSelf-history eligible
Mar 31, 20220/6 normalizedLevel 3Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20235/6 normalizedLevel 3Sep 30, 20235/6 normalizedLevel 3Dec 31, 20235/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 202.36%
- Current
- 242.52%
- Delta
- 40.16%
- Previous
- -115.39%
- Current
- -419.01%
- Delta
- -303.62%
- Previous
- -92.17%
- Current
- -18.36%
- Delta
- 73.81%
- Previous
- -623.82%
- Current
- -551.48%
- Delta
- 72.34%
- Previous
- 461.95%
- Current
- 394.69%
- Delta
- -67.27%
- Previous
- 168.79%
- Current
- 174.89%
- Delta
- 6.10%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ABCL Fundamental State →Transitioned To · ABCL GROWTH_INCREASED →Transitioned To · ABCL PROFITABILITY_INCREASED →Transitioned To · ABCL R_AND_D_INTENSITY_DECREASED →Transitioned To · ABCL SBC_INTENSITY_INCREASED →Transitioned To · ABCL Fundamental State →Transitioned To · ABCL CAPEX_INTENSITY_INCREASED →Transitioned To · ABCL CASH_GENERATION_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.